On 1 July 2022 the storage limit for eggs, sperm and embryos in the UK went from ten years to 55, with patients reconsenting every ten years. Most laboratories updated their consent paperwork within weeks. Very few updated their storage estate, and that is the gap worth thinking about, because a vessel bought for a ten year horizon is now expected to hold samples for a period longer than most of the staff will work in the sector.

What actually happens to an embryo at minus 196

Below roughly -130°C, biological material enters the glassy state. Molecular motion effectively stops, chemical reactions that degrade cell structures cease, and the sample waits. A blastocyst warmed after twenty years has the same biological age it had on the day it was frozen. That is the whole proposition, and it holds only while the temperature holds.

The danger zone is not room temperature. It is the band between about -130°C and -80°C, where molecular motion has resumed but the sample still looks frozen. Ice recrystallisation happens there, and it is cumulative and invisible. A sample that spends thirty seconds too long in warm vapour during a routine retrieval does not show you anything. The damage is recorded in the sample, not in your logbook.

Vitrification changed the technique and moved the risk

Slow controlled rate freezing lowers temperature at a programmed rate, typically a fraction of a degree per minute, allowing water to leave the cell gradually while a low concentration of cryoprotectant protects what remains. Vitrification does the opposite. Very high cryoprotectant concentration, minimal volume, and cooling so fast that the solution passes through the crystallisation range without forming ice at all, going straight to a glass.

Vitrification has largely displaced slow freezing for oocytes and embryos in routine IVF practice. It also moved the risk. Slow freezing was equipment dependent and forgiving of operator variation. Vitrification is the reverse. Loading volume, exposure time in the cryoprotectant, and the interval between removing the carrier from the media and plunging it are all operator controlled, and all of them are measured in seconds.

This is why controlled rate freezers have not disappeared. They remain the method of choice for a range of cell and tissue applications where sample volume makes vitrification impractical, and a laboratory doing both needs both.

Open carriers, closed carriers, and the argument that will not settle

Open carriers put the sample in direct contact with liquid nitrogen, which gives the highest cooling rate. Closed carriers seal the sample inside a straw or device before cooling, so cooling is slightly slower but there is no contact with the nitrogen.

The argument is about cross contamination. Liquid nitrogen is not sterile and can carry viable organisms between samples in a shared vessel. The counter argument is that documented transmission in clinical practice is vanishingly rare and that closed systems trade a real reduction in cooling rate against a theoretical risk. Both positions are defensible. What is not defensible is not having decided, not having documented the decision, and not being able to justify it when your inspector asks.

If you store for named patients across decades under the 55 year regime, the arithmetic of low probability events changes. Rare per year becomes considerably less rare across a fifty year store.

What 55 years does to your storage estate

Three things change, and none of them is about freezing technique.

Capacity planning stops being a rolling problem and becomes a cumulative one. Under a ten year limit, storage largely self cleared. Under 55 years with reconsent, the store grows and keeps growing. Model your intake against your withdrawal honestly and you will usually find you need more capacity sooner than the current vessel count suggests.

Vessel service life becomes a live issue. A vacuum insulated vessel does not last 55 years. The getter that maintains the annulus vacuum has finite capacity, and vessel performance follows it. Samples will outlive several generations of vessel, so transfer between vessels is now a planned, repeated, documented operation rather than a rare event, and every transfer is a warming risk.

Traceability has to survive staff turnover, software changes and relocation. Labelling has to remain legible at cryogenic temperature for decades. Consent status has to be tracked against a ten year reconsent cycle for every sample, which is an administrative load that ten year storage never imposed.

Monitoring is the part that pays for itself

In March 2018 two unrelated fertility clinics in the United States suffered cryogenic storage failures on the same weekend, and thousands of eggs and embryos were lost. The lesson taken across the sector was not about brands of vessel. It was that failures in this equipment are slow and silent, and that a store without continuous monitoring and alarms is relying on somebody walking past it.

Continuous level and temperature monitoring, alarms that reach a person outside working hours, oxygen depletion monitoring for the people in the room, and a written escalation procedure that has been tested rather than filed. Those four things are the difference between a maintenance job and an incident.

Getting the estate right

Specify on static evaporation rate rather than headline capacity. Plan for transfer between vessels as a routine event across a fifty year horizon. Choose labelling and identification rated for cryogenic temperature and long duration. Decide your position on open versus closed carriers, write it down, and be ready to defend it. Monitor continuously and alarm properly.

Cryolab supplies cryogenic storage vessels, controlled rate freezers, vitrification consumables, labelling systems and monitoring to IVF clinics, NHS trusts and biobanks in the UK and internationally, and has been active in the IVF sector since its earliest days. For help planning a storage estate against the current storage limits, contact Cryolab.